Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity
- PMID: 29843108
- DOI: 10.1016/j.ejmech.2018.05.032
Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity
Abstract
Nifedipine and isradipine are prominent examples of calcium channel blockers with a 1,4-dihydropyridine (DHP) scaffold. Although successfully used in clinics since decades for the treatment of hypertension, the binding mechanism to their target, the L-type voltage-gated calcium channel Cav1.2, is still incompletely understood. Recently, novel DHP derivatives with a condensed ring system have been discovered that show distinct selectivity profiles to different calcium channel subtypes. This property renders this DHP class as a promising tool to achieve selectivity towards distinct calcium channel subtypes. In this study, we identified a common binding mode for prominent DHPs nifedipine and isradipine using docking and pharmacophore analysis that is also able to explain the structure-activity relationship of a small subseries of DHP derivatives with a condensed ring system. These findings were used to guide the synthesis of twenty-two novel DHPs. An extensive characterization using 1H NMR, 13C NMR, mass spectra and elemental analysis was followed by whole cell patch clamp assays for analyzing activity at Cav1.2 and Cav3.2. Two compounds were identified with significant activity against Cav1.2. Additionally, we identified four compounds active against Cav3.2 of which three were selective over Cav1.2. Novel binding modes were analyzed using docking and pharmacophore analysis as well as molecular dynamics simulations.
Keywords: 1,4-dihydropyridine; Binding mechanism; Calcium channel; Hexahydroquinoline; Molecular modelling; Whole cell patch clamp.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.Pflugers Arch. 2014 Jul;466(7):1355-63. doi: 10.1007/s00424-013-1376-z. Epub 2013 Oct 23. Pflugers Arch. 2014. PMID: 24149495
-
Focusing on C-4 position of Hantzsch 1,4-dihydropyridines: Molecular modifications, enantioseparation, and binding mechanism to L- and T-type calcium channels.Eur J Med Chem. 2022 Dec 15;244:114787. doi: 10.1016/j.ejmech.2022.114787. Epub 2022 Sep 22. Eur J Med Chem. 2022. PMID: 36209630
-
Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.Eur J Med Chem. 2017 Jul 7;134:52-61. doi: 10.1016/j.ejmech.2017.03.080. Epub 2017 Apr 3. Eur J Med Chem. 2017. PMID: 28399450
-
Vascular effects of calcium channel antagonists: new evidence.Drugs. 2005;65 Suppl 2:1-10. doi: 10.2165/00003495-200565002-00002. Drugs. 2005. PMID: 16398057 Review.
-
Fused 1,4-dihydropyridines as potential calcium modulatory compounds.Mini Rev Med Chem. 2006 Jul;6(7):747-55. doi: 10.2174/138955706777698606. Mini Rev Med Chem. 2006. PMID: 16842124 Review.
Cited by
-
Synthesis, crystal structures, and Hirshfeld analysis of three hexa-hydro-quinoline derivatives.Acta Crystallogr E Crystallogr Commun. 2022 Oct 4;78(Pt 11):1089-1096. doi: 10.1107/S2056989022009495. eCollection 2022 Nov 1. Acta Crystallogr E Crystallogr Commun. 2022. PMID: 36380902 Free PMC article.
-
A Facile and Catalyst-Free Microwave-Promoted Multicomponent Reaction for the Synthesis of Functionalised 1,4-Dihydropyridines With Superb Selectivity and Yields.Front Chem. 2021 Mar 31;9:638832. doi: 10.3389/fchem.2021.638832. eCollection 2021. Front Chem. 2021. PMID: 33869142 Free PMC article.
-
1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori.Front Microbiol. 2022 May 25;13:874709. doi: 10.3389/fmicb.2022.874709. eCollection 2022. Front Microbiol. 2022. PMID: 35694298 Free PMC article.
-
Recent Progresses in the Multicomponent Synthesis of Dihydropyridines by Applying Sustainable Catalysts Under Green Conditions.Front Chem. 2021 Dec 22;9:800236. doi: 10.3389/fchem.2021.800236. eCollection 2021. Front Chem. 2021. PMID: 34993177 Free PMC article. Review.
-
Cardiomyocyte electrical-mechanical synchronized model for high-content, dose-quantitative and time-dependent drug assessment.Microsyst Nanoeng. 2021 Mar 25;7:26. doi: 10.1038/s41378-021-00247-0. eCollection 2021. Microsyst Nanoeng. 2021. PMID: 34567740 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources